Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Patrick Leigh Gomez"'
Publikováno v:
Journal of Clinical Oncology. 39:e21005-e21005
e21005 Background: Effect of PDL1 on OS in patients with MAC is controversial. This relationship has not been studied systematically in U.S. midwestern population, a largely homogenous Caucasian group. We examined the effect of PDL1 expression on OS
Publikováno v:
Journal of Clinical Oncology. 39:e21004-e21004
e21004 Background: Treatment of MAC is guided by MB. These include Programmed Death Ligand 1 (PDL1), Epidermal Growth Factor Receptor (EGFR), Anaplastic Lymphoma Kinase (ALK) & ROS1. There is little information available on P of MB in US Midwestern p
Autor:
Pankaj Kumar, Laura M. Miller, Christina Nicole Gomez, Matt Logsdon, Shawn Michael Seibert, Patrick Leigh Gomez
Publikováno v:
Journal of Clinical Oncology. 36:e18812-e18812
e18812Background: Improvement [I] in [QOL] and CRS varies greatly with different cannabis products. Evidence supporting specific cannabis products and frequency of use to improve QOL and CRS is lac...
Autor:
Sachdev P. Thomas, Timmy-Tai A Ho, Morgan N Medus, Jamie Harper, Pankaj Kumar, Kathryn L. Jackson, Nancy Williams, James L. Wade, Patrick Leigh Gomez
Publikováno v:
Journal of Clinical Oncology. 32:e19008-e19008
e19008 Background: Pazopanib is a novel, orally active, small molecule inhibitor targeting multiple tyrosine kinases and is indicated for the treatment of advanced renal cell cancer and advanced so...